NMR-Based Metabolomic Analysis of the Molecular Pathogenesis of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

NMR-Based Metabolomic Analysis of the Molecular Pathogenesis of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia

Published:2011-05-11 Issue:6 Volume:10 Page:2873-2881
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Cano Kristin E.¹,Li Liang¹,Bhatia Smita¹,Bhatia Ravi¹,Forman Stephen J.¹,Chen Yuan¹

Affiliation:

1. Department of Molecular Medicine, ‡Division of Hematopoietic Stem Cell and Leukemia Research, §Department of Population Sciences, and ∥Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, California 91010, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr200200y

Reference24 articles.

1. Treatment of non-Hodgkin lymphoma

2. Malignant neoplasms following bone marrow transplantation

3. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]

5. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer;Cell Biology and Toxicology;2024-05-01

2. Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia;BMC Medical Informatics and Decision Making;2024-01-02

3. Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS;Metabolites;2022-06-01

4. Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS;Frontiers in Pharmacology;2022-05-24

5. Pharmacometabolomics by NMR in Oncology: A Systematic Review;Pharmaceuticals;2021-10-02